IL6 and liver cancer: Consistent with this finding, combinational treatment involving IL-6 and PD-L1 neutralization effectively controlled tumor size and improved survival in HCC mouse model, suggestive of plausible targeting of this CAF-T-cell crosstalk in liver cancer.128